Biotechnology
TLX
7.49
price down icon3.35%   -0.26
after-market Handel nachbörslich: 7.49

Telix Pharmaceuticals Ltd Adr (TLX)
full-star
loading
Überblick Nachrichten Preisverlauf Forum Prognose
Schlusskurs vom Vortag:
$7.75
Offen:
$7.72
24-Stunden-Volumen:
300.55K
Relative Volume:
2.33
Marktkapitalisierung:
$2.51B
Einnahmen:
$417.75M
Nettoeinkommen (Verlust:
$32.27M
KGV:
76.82
EPS:
0.0975
Netto-Cashflow:
-
1W Leistung:
-7.53%
1M Leistung:
-24.72%
6M Leistung:
-53.39%
1J Leistung:
-51.36%
1-Tages-Spanne:
Value
$7.49
$7.7279
1-Wochen-Bereich:
Value
$7.49
$8.14
52-Wochen-Spanne:
Value
$7.49
$30.36

Telix Pharmaceuticals Ltd Adr Stock (TLX) Company Profile

Name
Firmenname
Telix Pharmaceuticals Ltd Adr
Name
Sektor
Healthcare (1130)
Name
Branche
Biotechnology (631)
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
554
Name
Twitter
Name
Nächster Verdiensttermin
2025-10-14
Name
Neueste SEC-Einreichungen
Name
TLX's Discussions on Twitter

Vergleichen Sie TLX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
TLX
Telix Pharmaceuticals Ltd Adr
 7.49 2.59B 417.75M 32.27M 0 0.0975
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 453.36 115.12B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 771.87 81.34B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 397.65 52.48B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
 840.95 51.59B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
 174.04 37.13B 447.02M -1.18B -906.14M -6.1812

Telix Pharmaceuticals Ltd Adr Stock (TLX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-18 Eingeleitet Citigroup Buy
2025-08-28 Herabstufung JP Morgan Overweight → Neutral
2025-07-03 Eingeleitet H.C. Wainwright Buy
2025-06-05 Eingeleitet Wedbush Outperform
2024-11-15 Eingeleitet UBS Buy

Telix Pharmaceuticals Ltd Adr Aktie (TLX) Neueste Nachrichten

pulisher
Dec 30, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages F5, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Dec 30, 2025
pulisher
Dec 30, 2025

TLX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX - GlobeNewswire Inc.

Dec 30, 2025
pulisher
Dec 23, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages F5, Inc. Stockholders to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.

Dec 23, 2025
pulisher
Dec 17, 2025

[6-K] Telix Pharmaceuticals Ltd Current Report (Foreign Issuer) | TLX SEC FilingForm 6-K - Stock Titan

Dec 17, 2025
pulisher
Dec 16, 2025

Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately - Finviz

Dec 16, 2025
pulisher
Dec 16, 2025

Telix Pharma (TLX) Makes Progress With New Study - Finviz

Dec 16, 2025
pulisher
Dec 08, 2025

Telix Pharmaceuticals (TLX) files Form 6-K on first ProstACT Global patient - Stock Titan

Dec 08, 2025
pulisher
Dec 02, 2025

ATTENTION NASDAQ: TLX INVESTORS: Contact Berger Montague About a Telix Pharmaceuticals Ltd. Class Action Lawsuit - Stock Titan

Dec 02, 2025
pulisher
Nov 28, 2025

Telix Pharmaceuticals (TLX) Sued After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman - Finviz

Nov 28, 2025
pulisher
Nov 26, 2025

Telix Pharmaceuticals (TLX) Hit with Investor Lawsuit Alleging Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman - Finviz

Nov 26, 2025
pulisher
Nov 25, 2025

Investors in Telix Pharmaceuticals Ltd. Should Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your RightsTLX - Finviz

Nov 25, 2025
pulisher
Nov 25, 2025

Berger Montague PC Investigating Claims on Behalf of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Investors After Class Action Filing - Stock Titan

Nov 25, 2025
pulisher
Nov 24, 2025

TLXTelix Pharmaceuticals Ltd ADR Latest Stock News & Market Updates - Stock Titan

Nov 24, 2025
pulisher
Nov 19, 2025

Berger Montague PC Investigating Claims on Behalf of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) After Class Action Filing - Stock Titan

Nov 19, 2025
pulisher
Nov 18, 2025

Telix Pharmaceuticals Limited Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsTLX - Stock Titan

Nov 18, 2025
pulisher
Nov 01, 2025

TELIX PHARMACEUTICALS INVESTIGATION ALERT: Bragar Eagel & - GlobeNewswire

Nov 01, 2025
pulisher
Oct 20, 2025

Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Inquire About Securities Class Action InvestigationTLX - cnhinews.com

Oct 20, 2025
pulisher
Oct 16, 2025

ContactThe Lethbridge HeraldNews and Sports from around Lethbridge - FinancialContent

Oct 16, 2025
pulisher
Oct 15, 2025

TELIX INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. - GlobeNewswire

Oct 15, 2025
pulisher
Oct 12, 2025

TLX Investor News: If You Have Suffered Losses in Telix - GlobeNewswire

Oct 12, 2025

Finanzdaten der Telix Pharmaceuticals Ltd Adr-Aktie (TLX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie TLX

biotechnology RPRX
$38.64
price down icon 0.90%
biotechnology GMAB
$30.80
price down icon 2.19%
biotechnology INCY
$98.77
price down icon 0.14%
biotechnology BNTX
$95.20
price down icon 0.08%
biotechnology ONC
$303.81
price down icon 0.30%
biotechnology INSM
$174.04
price down icon 0.03%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):